All In Biotech

Drug Trial Radar · NCT05936151

A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

A Phase 2b, Double-Blind Study to Investigate the Effect of Retatrutide on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 146 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

146

Actual

Start

Jul 20, 2023

Primary completion

Oct 1, 2025

Study completion Oct 21, 2025

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Jul 7, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to investigate the effect of retatrutide on renal function in participants with overweight or obesity and chronic kidney disease (CKD), with or without Type 2 Diabetes (T2D). The study will last around 31 weeks.

Conditions

  • Overweight or Obesity
  • CKD
  • Type 2 Diabetes

Interventions

  • RetatrutideDrug

    Administered Subcutaneously

  • PlaceboDrug

    Administered Subcutaneously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Measured Glomerular Filtration Rate (mGFR) Using Iohexol Clearance at Week 24Time frame: Baseline, Week 24

Locations

42 sites in 5 countries. Site status is shown where the registry gives one.

  • The Institute for Liver Health II dba Arizona Clinical Trials - Mesa

    Chandler, Arizona

  • Care Access - 801 South Power Road, Mesa

    Mesa, Arizona

  • Headlands Research - Scottsdale

    Scottsdale, Arizona

  • Medical Advancement Centers of Arizona

    Tempe, Arizona

  • Hope Clinical Research, Inc.

    Canoga Park, California

  • Catalina Research Institute, LLC

    Montclair, California

  • Peninsula Research Associates

    Rolling Hills Estates, California

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado

  • Teradan Clinical Trials, LLC

    Brandon, Florida

  • Suncoast Clinical Research, Inc.

    New Port Richey, Florida

  • Great Lakes Clinical Trials - Ravenswood

    Chicago, Illinois

  • Indiana University Health University Hospital

    Indianapolis, Indiana

  • Prime Health and Wellness/SKYCRNG

    Fayette, Mississippi

  • Palm Research Center Tenaya

    Las Vegas, Nevada

  • NYU Langone Hospital - Long Island

    Mineola, New York

  • Cleveland Clinic

    Cleveland, Ohio

  • Victorium Clinical Research - Houston

    Houston, Texas

  • Endocrine Ips, Pllc

    Houston, Texas

  • Tranquility Research

    Webster, Texas

  • Centricity Research Brampton Endocrinology

    Brampton, Ontario, Canada

  • Circulate Cardiac & Vascular Centre

    Burlington, Ontario, Canada

  • North York Diagnostic and Cardiac Centre

    North York, Ontario, Canada

  • Stouffville Medical Research Institute Inc.

    Stouffville, Ontario, Canada

  • Dr. Anil K. Gupta Medicine Professional Corporation

    Toronto, Ontario, Canada

  • Fadia El Boreky Medicine

    Waterloo, Ontario, Canada

  • Viacar Recherche Clinique

    Greenfield Park, Quebec, Canada

  • Diex Recherche Joliette

    Joliette, Quebec, Canada

  • 9109-0126 Quebec Inc.

    Montreal, Quebec, Canada

  • Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII

    Bergamo, Italy

  • Ospedale San Raffaele

    Milan, Italy

  • Centro Cardiologico Monzino

    Milan, Milano, Italy

  • Azienda Ospedaliera Universitaria Pisana

    Pisa, Tuscany, Italy

  • Clínica nuevas Tecnologías en Diabetes y Endocrinología (NTDE)

    Seville, Spain

  • Hospital Clinico de Valencia

    Valencia, Valenciana, Comunitat, Spain

  • Hospital Universitario Doctor Peset

    Valencia, Valenciana, Comunitat, Spain

  • City Hospital, Nottingham University Hospitals NHS Trust

    Nottingham, United Kingdom

  • Addenbrooke's Hospital

    Cambridge, Cambridgeshire, United Kingdom

  • FutureMeds Teesside - Middlefield Centre

    Stockton-on-Tees, Durham County, United Kingdom

  • Royal London Hospital

    London, England, United Kingdom

  • Futuremeds-Newcastle

    Newcastle, England, United Kingdom

Showing 40 of 42 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.